EN DE
Watch Noritake Co for free: we tell you when fair value or trend changes.
Data-driven stock valuation

Noritake Co (NO4) fair value: what the stock is really worth

As of Nov 17, 2026: fair value (intrinsic value) of Noritake Co stock €12.57, price €16.37, that is 23.2% below the price, quality 37 out of 100. Rating: overvalued. Calculated from audited financials with 8 of our 26 valuation models and 37 quality factors, updated daily.

  1. Keep an eye on it?Free in your watchlist: 5 stocks without an account, 10 with one Yes, for free

Industrials DE · Home Japan · ISIN JP3763000001

NC Noritake Co logo Some data Nov 15, 2026

Noritake Co

NO4 · F

Expensive (fair value 23% below the price) and weak company, but rising price: meets 1 of 3 rules.

Get notified free when this changes
Rising price (uptrend) 
Solidly profitable · 10.5% net margin (TTM) 
Low debt 
Ranks above peers (10/13) 
Last quarter vs. a year ago: revenue +19%, profit +64%. 
Expensive Growth (revenue 5y +6.0 %/yr in JPY) 
3.4% dividend yield · Watch coverage
Moderate moat 45/100 · thin data
Some data 
Fair value €12.57 · Overvalued 
Quality 37/100 
Negative free cash flow 
⚠ DilutionPrice via web search⚠ Thinly traded
Watch Noritake Co for free: we tell you when fair value or trend changes. Watch for free

What runs behind every stock

69 individual criteria per stock, every one traceable See the method →

Price vs Fair Value

€24.70 €5.93 Fair Value €12.57 Sep 2021 Nov 2026

White line = price, green steps = our fair value per fiscal year. As of Nov 15, 2026.

How to read this chart

60‑month range €5.93 – €24.70 · fair‑value band €8.47 – €13.90 · the €16.37 price screens above the €12.57 fair value. Green steps = our fair value per fiscal year (point-in-time, no hindsight). As of Nov 15, 2026.

Follow Noritake Co in your weekly email

Every Wednesday you see whether Noritake Co is on track or worth a review, plus price against fair value. Free, up to 3 stocks.

We send you a confirmation link. Unsubscribe with one click.

Which stocks are undervalued right now? Check free Discover now →

Company profile

Noritake Co., Limited with its subsidiaries, provides industrial, ceramic and material, and engineering products in Japan and internationally.

Show moreShow less

It offers grinding and polishing tools comprising grinding wheels, CBN wheels, diamond tools, coated abrasives, coolants, and recycled products; ceramics and materials, such as vacuum fluorescent display, electronic ceramic powders, thick film circuit substrate, decoration materials, engineering ceramics, electronic paste, and gypsum.

The company also provides engineering products comprising heating furnaces/kilns, actuator-less line mixers and related equipment, cutting machines, and filtration systems; and tabletop products, including chinaware for family table, gift, and ornament, as well as tableware for professional and institutional use.

The company was founded in 1904 and is headquartered in Nagoya, Japan.

Stock analysis

Noritake Co (NO4) currently trades at €16.37, while our model-based Fair Value estimate is €12.57, 23% below the price, so the stock looks overvalued today.

Show more

Valuation

Bull case: the Multiples group reads highest at a median of €53.90 per share, and 3 of the 8 models we run sit above the €16.37 price.

Bear case: the Asset-Based group reads lowest at €3.73, and 5 of the 8 models stay below the price. Data coverage for this calculation is medium.

Scenario range: €8.47 (bear) to €13.90 (bull), the price of €16.37 sits above it. Bear and bull are the same models on cautious and optimistic assumptions, a range, not a price target.

Quality & growth

The Quality Score stands at 37/100 (below-average quality), in the Industrials sector.

Expensive Growth: The company is growing, but growth may require heavy reinvestment or weak cash conversion.

Noritake Co reported revenue of ¥143B in FY2026 versus ¥128B in FY2022, a compound +2.9%/yr. Reported net income was ¥14.2B in FY2026, compounding +11.8%/yr from FY2022.

Key figures

Market cap €900M Small · P/E ratio 10.6 · P/S ratio 1.05 · EPS (TTM) €1.54 · Dividend yield 3.4% · Net margin 9.9% · Return on equity 9.4% · Return on assets (EBIT) 5.2% (5-year average).

Competitive moat

Our AI-assisted moat analysis scores the competitive advantage at 45 out of 100 (low confidence).

What moves the price

The share trades about 32% below its 52-week high and 24% above its 52-week low, currently below its 200-day average.

For context, the median of 10 Industrials peers we cover trades at 3% fair-value upside, at −23%, NO4 screens richer than that median.

Fair Value models

Bear €8.47 Fair Value €12.57 Bull €13.90
Price €16.37 · Downside -23.2%
Model ⓘEach model values the company its own way (discounted cash flow, earnings, assets, dividends). The fair value above starts from their evidence-weighted blend, not from a single model. In cyclical trough or peak years, after dilution or a stock split it is adjusted afterwards, so it can sit above or below the models. Based on fiscal year 2026 figures (about 8 months old). Earnings retained since then (€0.9746 per share) are deliberately not added. Bear ⓘBear = the cautious scenario: the same model computed with conservative anchors (lower growth, margins and valuation multiples). Together with Bull it frames a plausible valuation range, not a price target.BaseBull ⓘBull = the optimistic scenario: the same model computed with favourable anchors (higher growth, margins and valuation multiples). Together with Bear it frames a plausible valuation range, not a price target. If a model's bull case is above four times its base value, the table shows that limit with a > sign (like the overall Bull above): beyond it no assumption holds. Coverage ⓘCoverage = how well-backed THIS model's estimate is for this stock (0–100): how complete and reliable its input data are, and how well the model fits the company. The final Fair Value is an evidence-weighted blend, so better-evidenced models count more. Green ≥70, amber 50–69, grey below 50.
Best data coverage
Owner Earnings €4.36 €5.14 €6.10 78
Residual Income €13.99 €14.85 €16.41 76
Gordon GGM €5.50 €8.00 €10.36 69
All 8 models by family
DCF Models
Owner Earnings €4.36 €5.14 €6.10 78
Earnings-Based
Graham-Dodd €9.99 €21.67 €27.57 66
Dividend Discount
Gordon GGM €5.50 €8.00 €10.36 69
DDM Multi-Stage €5.50 €7.53 €9.57 67
Multiples
P/E Multiple €23.15 €30.86 €38.58 63
P/B Multiple €57.70 €76.94 €96.17 55
Asset-Based
NCAV (Graham) €2.46 €3.73 €4.67 54
Economic Profit
Residual Income €13.99 €14.85 €16.41 76

The fair value above starts from this blend and is adjusted for dilution from new shares.

Open the full fair value analysis →

Quality Score breakdown

Overall quality 37/100

It rates the business: profits, how they develop, real cash, balance sheet, investing and share count.

Profitability 41
How much profit the company makes from its sales and capital
Quality Growth 41
Are margins and returns getting better?
Cashflow 14
Do the profits arrive as real cash?
Financial strength 71
Debt, balance sheet and risk of trouble
Investment 56
Does it invest with discipline instead of growing at any price?
Low Volatility 63
How calm the share price moves, does not count
Price momentum 41
Price momentum of the last 3 to 12 months, does not count
Near the 52-week high 40
Distance to the 52-week high, does not count
New shares 0
Buys back shares or issues new ones?

Open the full quality analysis →

Revenue & earnings trend

Growth Quality ⓘGrowth is valuable only when reinvestment earns attractive returns (Aswath Damodaran): sustainable growth depends on return on capital, reinvestment and efficiency. Basis: total company revenue over the periods shown on the cards (3Y/5Y/all years), not per share, so a merger can show up as a growth jump; per-share earnings growth is in the value-creation card. 44/100
The company is growing, but growth may require heavy reinvestment or weak cash conversion.
Revenue growth 1 year
+3.4%
Revenue growth 3 years ⓘMeasures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump. Per-share growth (which does include buybacks) is in the value-creation card.
+0.8%
Revenue growth 5 years ⓘMeasures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump. Per-share growth (which does include buybacks) is in the value-creation card.
+6.0%
Start year 2021 (pandemic). Over 10 years: +2.7% a year
Revenue growth 12 years ⓘMeasures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump. Per-share growth (which does include buybacks) is in the value-creation card.
+4.1%
What shareholders gained per year (last 5 years), in JPY ⓘWhat the business itself delivers per year: earnings growth per share plus the dividend yield. This is what you get IF the market keeps valuing the stock the same way: it contains no assumption about the market changing its mind. Computed per share, so buybacks count and a merger does not pass as growth. For a company that pays no dividend it is pure earnings growth per share. Period: earnings growth per share as CAGR over the last 5 reported fiscal years (annual statements), plus the current dividend yield. The start value is the median of the three years around the start, so a single crisis year (a pandemic or a write-down) does not distort the rate. Measured in JPY: this currency has depreciated against the euro and dollar over the long run, so part of the nominal rate is currency erosion that never reaches a EUR/USD investor.
≈ +5.1%
Earnings growth per share plus dividend.
Earnings per share, growth per year≈ +1.7%
Dividend (yield on the price)3.4%
Pace: 5 vs 10 years ⓘTwo data points, not a trend model: earnings growth per share over the last 5 fiscal years against the last 10. Labelled "steady" when both rates are within 3 percentage points of each other, otherwise picking up or flattening. Shown only when ten years of history exist.1.7% vs −1.0%, steady
Profit margin 2021 to 2026 ⓘOperating margin then vs now, from reported annual statements. A falling margin after a boom year is the classic peak-earnings signal: the growth rate then leans on an inflated base.2% → 8%
⚠ Revenue per share shrinking 7.5%/yr over ~7Y (margins intact) ⓘStructural-decline marker: revenue PER SHARE has fallen over the last decade (robust median trend, not a single year). Backtested across 2005 to 2017, such businesses trailed the market by about 2.5 percentage points per year. Display only: it does not change the fair value or the quality score.
⚠ Base effect: the rate starts in the earnings trough around 2021 (starting value 237 per share, median 676 in 2017 to 2019). It measures the recovery from the trough, not lasting growth.

NO4 screens overvalued: fair value 23% below the price. Compare with 3M Company →

Compare Noritake Co with another stock

Price, fair value, quality and upside side by side.

Free, no sign-up

Peer GroupⓘHow this stock ranks against its industry: the green marker is this stock, the band is the typical 25–75% peer range, and the tick is the median.Conglomerates · 348 stocks

Beats the industry median on 9/12 measures
Overall it ranks above its industry peers.
Valuation
Quality Score 37 · Bottom 25%
Fair Value upside −23.2% · Below median
Profitability
Return on equity (12 months) 9.4% · Above median
Return on assets 6.2% · Top 25%
Net margin (12 months) 10.5% · Above median
Operating margin (12 months) 9.9% · Above median
Growth and dividend
Revenue growth (quarter YoY) 18.6% · Above median
Dividend yield (12 months) 3.4% · Above median

Valuation Multiplesvs Conglomerates median · lower = cheaper

P/E (12 months) 10.6× · Cheaper than median
P/B 0.94× · Cheaper than median
P/S (12 months) 1.05× · Pricier than median
EV/EBITDA 7.0× · Cheaper than median

Strength profile in five axes (Snowflake)

VALUEFUTUREPASTHEALTHDIVIDEND
This stock
VALUEFUTUREPASTHEALTHDIVIDEND
Sector peers
VALUE (fair-value potential)2 · sector 40
FUTURE (revenue growth)93 · sector 38
PAST (return on equity)38 · sector 26
HEALTH (low debt)100 · sector 90
DIVIDEND (yield)68 · sector 45

Context: sector, industry, market

Values & ESG

Does this company touch areas you may want to avoid? The classification is inferred from sector and industry.

None of the checked exposures detected

Similar stocks

10 more Conglomerates stocks, each showing price versus our Fair Value estimate.

Stock Price Fair Value vs Fair Value Compare
PT Astra International Tbk, ASII 5,700 IDR 11,000 IDR +93% vs NO4
SK Inc 034730 475,500 KRW 631,320 KRW +33% vs NO4
Honeywell International Inc HON $217.95 $245.42 +13% vs NO4
Jardine Matheson Holdings J36 $59.77 $66.74 +12% vs NO4
Kingdom Holding 4280 13.00 SAR 13.40 SAR +3% vs NO4
Koç Holding KCHOL 205.50 TRY 175.44 TRY −15% vs NO4
SGH Limited SGH A$41.06 A$34.87 −15% vs NO4
Keppel Ltd BN4 9.55 SGD 3.91 SGD −59% vs NO4
3M Company MMM $181.68 $73.02 −60% vs NO4
Swire Pacific Limited 0019 HK$112.80 HK$28.39 −75% vs NO4

Explore undervalued stocks

More undervalued Industrials stocks →

Try a ready-made strategy

Pick a strategy and jump into the live analysis with that exact screen applied.

🥇 Backtested Best 🏆 Big Names 💎 Quality on Sale 🚀 Profitable Growth 🧊 Quality Compounders 💵 Dividend Stars 📈 Strong Momentum 📉 Fallen Angels ⚖️ Deeply Undervalued 🔍 Small-Cap Gems 🏰 Moat at a Fair Price 💼 Insider Buying 🎩 Buffett-Style Quality 📚 Peter Lynch GARP 🧮 Greenblatt Magic Formula 🛡️ Graham Defensive

Discover tools

For bloggers & editors: embed code + live data

For bloggers, editors and developers: paste this into your site or blog (a “Custom HTML” block in WordPress), it shows the current fair value and links back here. Free, plain HTML, and welcome. Full data streams (CSV/JSON) at /developers.

Noritake Co: fair value per Fair Value Calculator

Cite: Fair Value Calculator (2026). "Noritake Co Fair Value". https://www.fairvalue-calculator.com/stock/NO4

Frequently asked questions

Is Noritake Co (NO4) overvalued or undervalued?
As of Nov 15, 2026, our model estimates a fair value of €12.57 versus a price of €16.37, about 23% lower (overvalued).
What is the fair value of NO4?
Our model-based fair value for Noritake Co is €12.57 (as of Nov 15, 2026), built from audited fundamentals. The current price: €16.37.
What is the quality score of NO4?
Noritake Co has a Quality Score of 37/100. It measures business quality (profitability, growth, cash flow, balance-sheet strength, investment discipline, share issuance). Market factors such as price momentum and volatility do not enter the number; they are shown separately in the detail view.
What is the price target for Noritake Co (NO4)?
Our model-based price target is the fair value of €12.57 (as of Nov 15, 2026) from 8 valuation models. Cautious scenario €8.47, optimistic scenario €13.90. It is a calculation from audited fundamentals, not an analyst target.
What is the Noritake Co stock forecast for 2026?
Our models put fair value at €12.57, about 23% lower versus a price of €16.37 (overvalued). Cautious scenario €8.47, optimistic scenario €13.90. The calculation is refreshed regularly with new filings.
What is the revenue of Noritake Co (NO4)?
Noritake Co reported trailing-twelve-month revenue of about ¥149B (latest available figure, as of Nov 15, 2026).
Does Noritake Co pay a dividend?
Noritake Co currently shows a dividend yield of 3.42% relative to its recent price (as of Nov 15, 2026).
How much is the dividend of Noritake Co (NO4) and when is the ex-dividend date?
Noritake Co has a dividend yield of 3.4%. The next ex-dividend date is Mar 30, 2027. A dividend has been paid every year since at least 2010. The payout ratio is 38.0% of earnings. Our assessment: Watch coverage. The dividend isn’t fully covered by free cash flow or earnings, part of it is funded from reserves or debt. Fine for now, but worth watching: if it stays uncovered, the dividend could be cut.
What is the intrinsic value of Noritake Co (NO4)?
Intrinsic value and fair value mean the same thing: what the business is worth on its numbers, independent of the share price. For Noritake Co it is €12.57 per share (as of Nov 15, 2026), against a price of €16.37. It is the blended result of 8 valuation models in 6 families (DCF Models, Earnings-Based, Dividend Discount, Multiples, Asset-Based, Economic Profit).
Is Noritake Co stock overvalued or undervalued in 2026?
As of Nov 15, 2026, NO4 trades above its calculated fair value: price €16.37, fair value €12.57, a gap of about −23% (overvalued). The calculation is refreshed with each new quarterly report, so the verdict can change during the year.
Is fair value the same as the market price of NO4?
No. The price is what the market pays today (€16.37); the fair value is what the company's own numbers justify (€12.57). For Noritake Co the two are €3.80 per share apart. That gap is exactly why we show both numbers side by side.
How much is Noritake Co worth?
The market values Noritake Co at about €900M (market capitalisation, as of Nov 15, 2026). Per share that is €16.37; our models calculate a fair value of €12.57 per share.
What do the bullish and bearish scenarios say about NO4?
Our models span a range for Noritake Co: cautious scenario €8.47, base €12.57, optimistic €13.90 per share (as of Nov 15, 2026, price €16.37). The range comes from different growth and margin assumptions, not from analyst opinions.
What is the P/E ratio of NO4?
Noritake Co trades at a price-to-earnings ratio of 10.6 (as of Nov 15, 2026). A P/E on its own says little: it compares the price with ONE year of profit, while our fair value of €12.57 is built from several models across several years. Other multiples: P/B 0.9, P/S 1.0, EV/EBITDA 7.0.
How solid is the balance sheet of Noritake Co (NO4)?
Balance-sheet figures for Noritake Co (as of Nov 15, 2026): return on equity 9.4%. They feed the Quality Score of 37/100, which measures business quality independently of the share price.
How far is NO4 from its 52-week high?
Noritake Co trades at €16.37, about 32% below its 52-week high of €23.99 and 24% above the low of €13.16 (as of Nov 16, 2026). Distance from the high says nothing about value: that is what the fair value of €12.57 is for.
Which stocks are comparable to Noritake Co?
From the same area (Industrials) we also value 3M Company, Honeywell International Inc, Swire Pacific Limited, SGH Limited, among others. Each of them has its own fair-value calculation on this site using the same models, so the comparison is like for like.
Is Noritake Co stock attractive at the current price?
The data as of Nov 15, 2026: price €16.37, calculated fair value €12.57 (−23%), Quality Score 37/100, from 8 models. Whether that fits your horizon and risk tolerance is your call. We provide the calculation, not investment advice.
How is the fair value of NO4 calculated?
We run Noritake Co through 8 models from 6 families: DCF Models, Earnings-Based, Dividend Discount, Multiples, Asset-Based, Economic Profit. Every model gets the same audited fundamentals; the fair value of €12.57 builds on their evidence-weighted average, with the spread shown as a cautious and an optimistic scenario.
Is it still worth investing in stocks now?
The global stock market currently sits 13.6% above its aggregate fair value. Noritake Co itself currently trades above fair value. An expensive market is no reason to stay out and no reason to buy everything at once: keep a broad savings plan running, buy single stocks only with money you can do without, and hold part of your money liquid while the market is high. The full picture including sectors is on is it worth investing now.
What is the share price of Noritake Co (NO4)?
The closing price on Nov 17, 2026 was €16.37. Our model-based fair value is €12.57, about 23% lower (overvalued). We carry closing prices from our data provider, not a live tick.
What should I pay attention to with Noritake Co right now?
The price sits above even our optimistic bull case (€13.90). The favourable scenario is already priced in. Weak quality (37/100) and above fair value at the same time, the margin of safety is missing on both counts.

Key figures of Noritake Co

How large is the market capitalisation of Noritake Co (NO4)?
The market capitalisation of Noritake Co is €900M. The stock-market value of the whole company: share price times number of shares. It is what the market asks for the entire business today.
What is the P/S ratio of Noritake Co (NO4)?
The price-to-sales ratio of Noritake Co is 1.05 (P/E × margin). Price to sales: market value relative to yearly revenue. Useful when profit is thin or distorted.
What are the earnings per share of Noritake Co (NO4)?
Earnings per share at Noritake Co are €1.54 (price ÷ EPS = P/E 10.6). Earnings per share over the last twelve months: total profit spread across every single share.
What is the dividend yield of Noritake Co (NO4)?
The dividend yield of Noritake Co is 3.4% (payout 36.4%). Yearly dividend relative to the share price. 3% pays 3 per 100 invested. Below: how much of profit is used for it.
What is the net margin of Noritake Co (NO4)?
The net margin of Noritake Co is 9.9% (fiscal year 2026). How much of every unit of revenue ends up as profit. 10% means 10 cents of profit per dollar of sales.
What is the return on equity of Noritake Co (NO4)?
The return on equity (ROE) of Noritake Co is 9.4% (last twelve months). Profit relative to shareholders' equity, how efficiently the company works with its owners' money.
What is the EBIT return on assets of Noritake Co (NO4)?
On an EBIT basis the return on assets of Noritake Co is 5.2% (avg 5y). Operating profit (EBIT) relative to everything the company owns, as a multi-year average. It describes the business model rather than one good or bad year.
What is the operating margin of Noritake Co (NO4)?
The operating margin of Noritake Co is 9.9% (last twelve months). Profit from the core business (before interest and taxes) relative to revenue.
How fast is revenue growing at Noritake Co (NO4)?
Revenue at Noritake Co is growing 18.6% versus a year earlier (3y avg +0.8%). How much revenue grew versus a year earlier (YoY). The 3-year average next to it puts the single year in context.
How fast are earnings growing at Noritake Co (NO4)?
Earnings per share at Noritake Co are growing 63.6% versus a year earlier. How much earnings per share grew versus a year earlier.
How much free cash flow does Noritake Co (NO4) generate?
The free cash flow of Noritake Co is −¥4.1B (fiscal year 2026). The cash truly left after running and investing in the business, this is what pays dividends and buybacks.
Free · no account needed

Watch Noritake Co in the live analysis

One click puts Noritake Co on your watchlist: fair value and trend at a glance, plus comparison, the diversification check and the 27,000+ stock screener.

Watch for free →

Zero risk: nothing is ever charged. Your watchlist is yours, with or without an account.